BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND AR, P10275, 367, ENSG00000169083, DHTR, SBMA, HUMARA, SMAX1, RP11-383C12_1, TFM, AIS, NR3C4, KD AND Prognosis
10331 results:

  • 1. [The pathological characteristics and prognostic analysis of medullary thyroid microcarcinoma].
    Li DP; Zhang JM; Zhang YH; Hu LF; Gao Y; Wei SF; Zheng XQ
    Zhonghua Yi Xue Za Zhi; 2024 May; 104(20):1825-1830. PubMed ID: 38782750
    [No Abstract]    [Full Text] [Related]  

  • 2. Prophylactic central lymph node dissection in cN0 papillary thyroid cancer: a comparative study of via breast and transoral approach versus via breast approach alone.
    Qiu R; Fu J
    Front Endocrinol (Lausanne); 2024; 15():1356739. PubMed ID: 38774230
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Ciprofol suppresses proliferation, invasion and migration of human pancreatic cancer cells.
    Han F; Dong S; Chen Z; Dong C; Shi H; Du Y; Zhou W
    Pak J Pharm Sci; 2024 Mar; 37(2):327-336. PubMed ID: 38767100
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Dual‑regulated oncolytic adenovirus carrying
    Zhao T; Ye W; Zhang R; Zhu X; Shi Q; Xu X; Chen W; Xu L; Meng Y
    Mol Med Rep; 2024 Jul; 30(1):. PubMed ID: 38757346
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. A clinicopathological study of non-functioning pituitary neuroendocrine tumours using the World Health Organization 2022 classification.
    Woo CS; Ho RS; Ho G; Lau HT; Fong CH; Chang JY; Leung EK; Tang LC; Ma IK; Lee AC; Lui DT; Woo YC; Chow WS; Leung GK; Tan KC; Lam KS; Lee CH
    Front Endocrinol (Lausanne); 2024; 15():1368944. PubMed ID: 38756997
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. CircAGFG1 Promotes Ovarian cancer Progression Through the miR-409-3 p/ZEB1 Axis.
    Luo J; Zhong H; Guo M; Xiao P; Cao R; Zhao M; Jing Y
    Technol Cancer Res Treat; 2024; 23():15330338241252423. PubMed ID: 38752261
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. EMP1 correlated with cancer progression and immune characteristics in pan-cancer and ovarian cancer.
    Zhang J; Yang J; Li X; Mao L; Zhang Y; Liu Y; Bao Y
    Mol Genet Genomics; 2024 May; 299(1):51. PubMed ID: 38743077
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. [The clinicopathological features of adult thyroid tumors with DICER1 mutation].
    Tang J; Huang JJ; Luo YL; Zhang LK; Wang QQ; Chen J; Liu ZY
    Zhonghua Yi Xue Za Zhi; 2024 May; 104(18):1623-1627. PubMed ID: 38742350
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. WHO 2022 updates on follicular cell and c-cell derived thyroid neoplasm.
    Goswami P; Patel T; Dave R; Singh G; Singh A; Kalonia T
    J Med Life; 2024 Jan; 17(1):15-23. PubMed ID: 38737660
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Columnar Cell Thyroid Carcinoma: A Heterogeneous Entity Demonstrating Overlap Between Papillary Thyroid Carcinoma and Follicular Neoplasms.
    Higgins KE; Sadow PM; Johnson DN; Wang P; Wanjari P; Cipriani NA
    Head Neck Pathol; 2024 May; 18(1):39. PubMed ID: 38727854
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. A Competing Risk Nomogram for Prediction of prognosis in Patients With Primary Squamous Cell Thyroid Carcinoma.
    Tian Y; He L; Zhang B; Deng L; Wang J
    Technol Cancer Res Treat; 2024; 23():15330338241254059. PubMed ID: 38725285
    [No Abstract]    [Full Text] [Related]  

  • 12. Prognostic value of postoperative anti-thyroglobulin antibody in patients with differentiated thyroid cancer.
    Zhao Y; Mu Z; Liang D; Zhang T; Zhang X; Sun D; Sun Y; Liang J; Lin Y
    Front Endocrinol (Lausanne); 2024; 15():1354426. PubMed ID: 38721144
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. [Analysis of factors affecting the prognosis of patients with pancreatic cancer patients with obstructive jaundice].
    Zhang L; Li M; Sun QF; Yu HP
    Zhonghua Nei Ke Za Zhi; 2024 May; 63(5):474-479. PubMed ID: 38715484
    [No Abstract]    [Full Text] [Related]  

  • 14. Blockade of histamine receptor H1 augments immune checkpoint therapy by enhancing MHC-I expression in pancreatic cancer cells.
    Zhong P; Nakata K; Oyama K; Higashijima N; Sagara A; Date S; Luo H; Hayashi M; Kubo A; Wu C; He S; Yamamoto T; Koikawa K; Iwamoto C; Abe T; Ikenaga N; Ohuchida K; Morisaki T; Oda Y; Kuba K; Nakamura M
    J Exp Clin Cancer Res; 2024 May; 43(1):138. PubMed ID: 38715057
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Prognostic significance of preoperative lymphocytes, albumin, and neutrophils (LANR) index in resectable pancreatic ductal adenocarcinoma.
    Zhuang J; Wang S; Wang Y; Wu Y; Hu R
    BMC Cancer; 2024 May; 24(1):568. PubMed ID: 38714979
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Treatment strategies for borderline resectable pancreatic neuroendocrine tumors: a narrative review.
    Chang JY; Ruff SM; Cloyd JM
    Chin Clin Oncol; 2024 Apr; 13(2):25. PubMed ID: 38711178
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Adjuvant chemotherapy omission after pancreatic cancer resection: a French nationwide study.
    Poiraud C; Lenne X; Bruandet A; Theis D; Bertrand N; Turpin A; Truant S; El Amrani M
    World J Surg Oncol; 2024 May; 22(1):123. PubMed ID: 38711136
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Time Kinetics and prognosis roles of calcitonin after surgery for medullary thyroid carcinoma.
    Guo F; Fu G; Li F; Hua Y; Wang Z; Zheng X; Zhao J; Gao M
    World J Surg Oncol; 2024 May; 22(1):121. PubMed ID: 38711029
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. piR-1919609 Is an Ideal Potential Target for Reversing Platinum Resistance in Ovarian cancer.
    Yan Y; Tian D; Zhao B; Li Z; Huang Z; Li K; Chen X; Zhou L; Feng Y; Yang Z
    Technol Cancer Res Treat; 2024; 23():15330338241249692. PubMed ID: 38706262
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. CLIP170 inhibits the metastasis and EMT of papillary thyroid cancer through the TGF-β pathway.
    Ma B; Xu Y; Gao H; Yang Y; Pan Y; You C
    Med Oncol; 2024 May; 41(6):137. PubMed ID: 38705933
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 517.